Abstract:AIM:To examine the effect of celecoxib on tumor growth and angiogenesis in an orthotopic implantation tumor model of colon cancer.METHODS:Human colorectal adenocarcinoma HT-29 cells were implanted subcutaneously in nude mice. Four groups of animals received different doses of celecoxib after tumor implantation. After 42 days, all animals were evaluated for changes in body weight, the volume and weight of colorectal tumors, and tumor growth inhibition. The content of prostaglandin E(2) (PGE(2)) in the tumor tissue homogenate was estimated by radioimmunoassay (RIA). Cyclooxygenase-2 (COX-2) and CD34 expression in tumor tissue was assessed by immunohistochemistry, and the microvessel density (MVD) of tumor tissue was determined. Apoptosis of the tumor cells was detected by the terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL). The expression of vascular endothelial growth factor (VEGF) mRNA and matrix metalloproteinase-2 (MMP-2) mRNA extracted from the tumor tissue was analyzed by reverse transcriptase polymerase chain reaction (RT-PCR).RESULTS:There was no statistically significant change in the animals' body weight between the treatment groups. However, with increasing doses of celecoxib, the volume and weight of the tumor decreased. The rates of tumor growth inhibition for the L (low), M (medium) and H (high) groups were 25.30%, 38.80%, and 76.92%, respectively, which were significant compared to the C (control) group. There were significant differences in COX-2 expression in the tumor tissue between all groups, except between the L and M groups. Celecoxib exposure also reduced PGE2 levels in the tumor tissue homogenates. The level of PGE(2) correlated to the weight of tumor (r=0.8814, P < 0.05) and to COX-2 expression (r=0.8249, Puse < 0.05). Compared to the control group, the tumor cells from celecoxib-treated mice had a significantly higher apoptotic index. Celecoxib also decreased CD34(+) expression in tumors from treated mice. There were significant differences in the MVD between all groups except between groups H and M. Celecoxib significantly reduced the expression of VEGF and MMP-2 mRNA in the group H but not in L and M groups. The MVD in tumor tissue was closely related to the PGE2 levels, as well as the expression of VEGF and MMP-2 mRNA (r = 0.9006, r = 0.8573 and r = 0.6427, respectively; P < 0.05).CONCLUSIONS:By inhibiting COX-2, PGE(2) synthesis, and VEGF and MMP-2 mRNA expression in tumor tissue, celecoxib enhances tumor cell apoptosis, thereby inhibiting the growth and angiogenesis of orthotopically implanted tumors in a mouse model of human colorectal cancer.

Effect of Celecoxib on Growth and Angiogenesis of Orthotopic Transplantation Tumor of Experimental Colorectal Cancer

[Effect of Selective Cyclooxygenase-2 Inhibitor Celebrex on Expression of Vascular Endothelial Growth Factor (VEGF) in Pancreatic Carcinoma].

Impact of the Selective Cyclooxygenase-2 Inhibitor Celebrex on Angiogenesis in Pancreatic Carcinoma

Celecoxib Inhibits Tumor Growth and Angiogenesis in an Orthotopic Implantation Tumor Model of Human Colon Cancer.

Cyclooxygenase-2 Induces Angiogenesis in Pancreatic Cancer Mediated by Prostaglandin E-2

The Effects of Inhibited the Proliferation by Celecoxib in Human Primary Hepatic Cancer Xenograft of Nude Mice in Vivo

Experimental Study of Inhibitive Effects of Celecoxib on the Proliferation of Lung Cancer Cells and Angiogenesis

Inhibitory Effect of a Non-Steroidal Anti-Inflammatory Drug,celecoxib,on Angiogenesis in Lung Cancer

Therapeutic Effects of COX-2 Inhibitor Celecoxib on Nude Mice Bearing Human Pancreatic Cancer Xenograft

Antitumor and anti-metastatic effects of cyclooxygenase-2 inhibition by celecoxib on human colorectal carcinoma xenografts in nude mouse rectum

Effects of COX-2 and Celecoxib on Angiogenesis in Liver Metastasis of Colon Cancer in Mice

The effect of COX-2 inhibitor on bladder cancer

Establishment of Orthotopic Transplantation Model of Human Colonic Tumor in Nude Mice

Experimental Study on Inhibitive Effect of a Non-Steroidal Anti-Inflammatory Drug,celecoxib,on Lung Adenocarcinoma

Effection of Celecoxib Combined with 5-Fu on Treatmeat of Human Colorectal Cancer in BALB/C Nude Mice Subcutaneous Xenograft Model

The Effect of a Selective COX-2 Inhibitor on Cell Growth in Human Colorectal Cancer Cell Line

Modulating Effect of Celecoxib to Suppress Proliferation and the Molecular Mechanism in Caco-2 of Colon Carcinoma Cell Line

Effect of Celecoxib on Proliferation, Moving and Invasiveness of Glioma Cells

Inhibition Effects of Celebrex on the Proliferation of Lewis Lung Cancer Cells and Growth of Transplanted Lewis Lung Carcinoma

The Effects of Selective Cyclooxygenase-2 Inhibitors on the Growth of Human Pancreatic Cellular Carcinoma

Study on Enhancement of Radiosensitivity in Colon Cancer Carcinoma Cell Line HT-29 by Celecoxib in Vitro and in Vivo